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Lung defenses include mucociliary transport a s well as phagocytic cells, lymphocytes, and immunoglobulin secretion. Since mucociliary transport in some C F patients is compromised (5) . clearing of the bacteria becomes more dependent on the efficient action of t h e phagocytic cells. Previous studies in our laboratory (2) and by Biggar, e t al. ( I ) have shown that C F serum impairs phagocytosis of Pseudomonas by rabbit alveolar macrophages. This report presents experimental observations indicating t h e presence of an inhibitory activity in C F serum which impairs phagocytosis of Pseudomonas by human a s well a s rabbit alveolar macrophages.
MATERIALS AM) METHODS
All studies were carried out under an approved human investigation protocol and a f t e r securing lnformed consent from all participants.
Preparation of Rabbit Alveolar Macrophages
Rabbit alveolar macrophages were obtained by pulmonary lavage according t o the method of Uyrvik, e t al. (13) as modified by Brain and Frank (3) . Disease-free New Zealand rabbits weighing 3 4 kg were sacrificed with pentobarbital and the lungs excised and placed rn a 3 7 '~ water bath. The lungs were lavaged with sterile normal saline and the lavage fluid passed through a blood filter (Travenol Laboratories, Inc., Deerfield, 111.). Seven t o eight lung washings were p w l e d (ca 400 ml), centrifuged a t 400g for 10 minutes; whereupon the cell pellet y a s washed three times w i y normal saline. The average yield per rabbit was 3.9 X 10 cells (range 1.4 -7.3 X L O ). More than 95% of the cells isolated were macrophages, and greater than 95% of these excluded trypan blue.
Preparation of Human Alveolar Macrophages
Alveolar macrophages were obtained from normal, healthy adult volunteers by fiberoptic bronchoscopy. Brief medical histories were obtained on all volunteers, none of whom had recent acute p l m o n a r y infection or a history of chronic pulmonary disease. A flexible bronchoscope was passed transnasally with topical anesthesia (lidocaine or cocaine) into a segment of the lingula. With the tip of the bronchoscope wedged into a segmental or subsegmental airway, aliquots (60-75 ml) of sterile 0.9% saline were alternately instilled by gravity and withdrawn by gentle aspiration with a syringe. A total volume of 40'2-600 ml was usually employed, of which all but 10'2-150 ml was recovered. The lavage procedure required approximately 10 minutes. No subject experienced adverse effects. Bronchoscopic findings were within normal limits, except in some of the cigarette smokers who had evidence of increased secretions in t h e airways. The smokers in the study smoked between 10-20 cigarettes per day. Smokers were used because of the greater cell yield and previous demonstration of no significant difference in phagocytosis of Pseudomonas by alveolar macrophages from smokers and no smokers (b6). The average yield from yn-smokers was 7.9 X cells ( r y g e 2.6 X 10"-18 X 10 ) and from smokers 5.6 X 10 cells (range 0.8 X 10 -13 X 10 ). Zlore than 89% of the cells isolated were macrophages a s determined by a nonspecific esterase stain ( I I), and greater than 95% of these excluded trypan blue.
Establishment of Macrophage Cultures
Macrophages were cultured in tissue culture chambers (2 or 4 chamber units, LabTek Products, Div. Miles Laboratories, Inc., Naperville, 111. ) containing UcCoys 5A medium (Grand Island Riological Co., Grand Island, N.Y.) supplemented wrth 10% heatinactivated f e t a l calf serum, 2.9 mglml L-glutamine, and antibiotics (gentamicin sulfate, penicillin, gtreptomycin and amphotericin B). The two chamber slide? were seeded with IIX 10 cells per chamber and t h e four chambgr slides with 5 x 10 cells per chamber.
Cultures were incubated for 24 hours a t 37 C in a humidifred 5% CO atmosphere. To insure comparability of cell cultures, individual cultures were checked for uniformity of the cell poprlat~on by examination with an inverted microscope a t IOOX magnification.
Reparation of Radioactive Bacteria
Four strains of Pseudomonas aeru inosa were obtained from C F sputum or throat cultures and two nowiTF strains w e h d from urine cultures. The same non-CF strain of P. aeru inosa was used for all assays except those comparing d~f f e r e n t strains (see ~a b l ; h m e experiments, organisms were used inl addition t o t h e P.
aeruginosa; and these include a single strain of Serratia marcescenp, from Dr. Paul Q w e a t t h e University of Minnesota and a sinple strain of Staphylococcus e, a C F sputum isolate. The isolate of P. aeru inosa and S marcescens were grown 15-18 hours a t 3 7 '~ with shaking in mi%m+(Kos~' Citrate) supplemented with 0.5% Casamino Acids (Difco Laboratories, Detroit, Michigan). Sta h lococcus aureus was grown in minimal salts supplemented wit) 0.5% yeast ext-lt~were diluted t o mid log phase and I50 uCi of H-leucine (specific activity 30-50 Cilmmol, ICN Pharmaceuticals, Inc., Iryne, California) were added t o P. aeru 'nosa and marcescens, while 250 uCi of H-thymidine (specific activity 4~6 0 & , ~m e r :
shamlSearle, Arlington Heights, Illinors) were added t o I. aureus. After 1 t o 2 hours further incubation, the bacteria were harvested by centrifugation a t 3,000g for 10 minutes and washed with normal saline until no radioact~vity w~ detected in t h e wash. The specific activity of the bacteria was always greater than 10-cpmlbacterium.
Patient and Normal Control Serum Samples
Controls were age and sex matched t o patrents using serum samples from children on t h e orthopedic wards and adult hospital workers. Serum was also collected from eight obligate heterozygotes (Mothers of C F patients used In the study). The age range of t h e patients was 9 months t o 31 years and t h e range of t h e controls was 3 years t o 40 years. CF was diagnosed by a positive sweat test and either typical pulmonary or gastrointestinal symptoms or a confirmed family history of CF. Respiratory tract cultures are obtained on these patients approximately every six weeks. Clinical evaluation was based on a modification (7) of t h e Shwachman and Kulczycki (16) C -Poor clinical condition: x-ray and PE < 12; VCc 55% and RV/TLC> 0.5.
All patients were off antibrotics for a t least 48 hours prior to obtaining blood samples.
Serum Samples
Depending on the age and size of the subject, 10 t o 30 ml of blood were obtained for t h e study. Initially t h e blood was collected in plastic tubes. Subsequent samples were collected in glass when this proved more satisfactory. After clotting a t room temperature, t h e blood was centrifuged a t 1,500g and the serum decanted. The serum was than aliquoted and samples which were not used immediately were frozen a t -70'~. In some experiments pooled normal human sera (Grand Island Biological Company) were used a s controls.
Phagocytosis Assay
The 24-hour macrophage monolayer cultures were washed three times with Hank's balanced salt solution (BSS) before adding t h e reaction mixture which consisted of 0.1 ml of a I:I dilution of a C F or a normal serum sample in BSS, 0.1 ml of the bacterial suspension, 0.8 ml of BSS. All components were preincubated individually a t 37 C. The ratio of bacteria t o cells varied between 10:l and 100:l. The concentration of the bacterial inoculum was estimated by optical density a t 520 nm and was confirmed by subsequent plate counts. The variation in the ratio of bacteria t o cells over this range did not a f f e c t t h e comparison of phagocytosis in t h e presence of C F and normal serum since the ratio was constant within each experiment. The e f f e c t of C F serum on phagocytosis was compared with a parallel study of normal serum; each assay included duplicate tests of both C F and normal serum samples. The chambers were then incubated a t 3 7 '~ with gentle shaking. After 30 minutes t h e supernatant was decanted and the cell layer washed six times with cold BSS. One ml of cold distilled water was then added t o each culture t o lyse the cell monolayer. The cells were allowed t o swell for a t least 30 minutes in the cold and then disrupted by vigorous pipetting. Observations of t h e culture vessels with an inverted microscope (100X) routinely revealed all the cells t o be disrupted by this procedure. One tenth ml of the lysate was then counted in Triton X-100 toluene scintillation fluid. Calculations were as follows: cpm in lysate from each culture = % phagocytosis cpm of bacteria added t o each culture
If more than one control was used in an experrment, the median control was used in the calculation. For statistical evaluation, t h e paired t test was used t o compare t h e per cent phagocytosis in the presence of C F serum t o the per cent phagocytosis in the presence of normal control serum.
A~g l u t i M t i n~ Antibody Titer
The antibody titer of the serum samples against the b a c t e r~a used in the phagocytosis assay was determined by slide agglutination. All serum samples were titered against a single preparation of the antigen which was prepared by growing the bacteria overnight a t 3 7 '~ in 50 ml of Mueller-Hinton broth. The culture was centrrfuged, washed extensively with normal saline, and the final pellet resuspended in 10 ml normal saline. Dilutions of the bacterial suspension were mixed with undiluted serum samples and optimal agglutination used t o select the standard antigen dilution. Each serum was diluted serially whereupon 50 2 of each dilutlon war placed on a glass slide and mixed with 50 2 of t h e standard bacterial susoension. The slide was gently rotated and the endpoint read a s the last dilution which produced +2 agglutrnat~on.
Serum Effects on Phagocytos~s
The phagocytosis of Pseudomonas by rabbit alveolar macrophages was invest~gated i n the presence of serum from 49 CF patlents and matched controls (assayed i n parallel). The comparison of phagocytosrs In the presence of the two types of serum revealed siqn~frcant inhib~tlon by the CF serum (P<.001). Table I shows results from all of these patlents.
Of the 49 patients' serum samples studied, 40 consistently showed>60% inhibltron, 3 showed no inhihition and 6 were i n the range of 20-608 lnhibitlon of Pseudomonas phagocytos~s. Figures I A and 18 show microscopically the effect of C F and normal serum on phagocytosis. Racteria are assocrated with alveolar macrophages incubated i n normal serum, i n contrast, few bacterla are associated with cells i n the presenre of CF serum. The phagocytosis of 5. aureus and 5. marcescens was also evaluated, using 13 and 6 serum samples respectlveiy (Table 2 ). j i a f l r t i c a l l y s i s uslng the palred t test shouzed no significant C F serum inhibition of phagocytosis of elther organism.
Tahle I also shows the percent inhibltion of Reudomonas phaqocytosis by human alveolar macrophages In the presence of serum from 13 CF patients. The cross-species correlation is excellent. The I 2 patients who showed inh~bition i n the rabbit system also inhibited In the human system, whlle one patient (patlent 7) failed to inhibit i n either system. The rnh~bjtion of CF serum of Pseudomonas phagocytosls was observed wlth both smoker and non-smoker cells. The palred t test was not performed in these stud~es because all of the serum samples tested with human cells were selected on the basis of prevkous experience with rabbit cells.
The assay (rabb~t cells) was rrpeated usinp. 41 of the 49 patients and again significant inhibition of phagocytosls was demonstrated (PC.001). Only 4 patient serum samples (pat~ents 7, 42, 43, A.S.) have been found to consistently show no inh~bition.
All of these ~ndlvlduals *,ere i n good cl~nrcal condition. None of the four donors had mucoid Pseudomonas. One was an infant wlthout Pseudomonas and two had had nonmucold Reudomonas only rarely. A second infant (A.S.), who was not In the original statist!cal evaluation, dld not show lnhrbltion and was also without Pseudomonas. In the group whlch consistently demonstrated inhibition of Pseudomonas phagocytosis, there were 7 individuals u,ithout rvldence of chronic Pseudomonas infection of the lung. One individual (patient 22) rn particular has never had a posltrve culture In over 19 years since diagnos~s of CF, and yet his serum consistently ~n h i b~t e d
Pseudomonas phagocytos1s.
4 plot of per cent inhibltion of Pseudomona-phagocytosls versus agglutinating antibody titer for 42 patients rs shown In Figure2. There does not appear to be a correlation between the degree of inhib~tron of phagocytosis and agglutinating antibody titer. In fact, there were individuals whose serum showed marked inhibition i n both the low and high tlter groups. However, the individuals who did not show inhibition had low titers (points a, b, and c In Figure 2 ). The serum titers of 25 control subjects were determined, demonstrating that I 6 had no titers, 6 had titers of 1:2, and 3 had titers of I:4.
Effect of CF Patient History
The culture history of each of the 50 C F patients used in the study was reviewed (Table I ). The 4 oatlents who showed no Inhibition were discussed ~reviouslv. Of the remaining 46, 29' patients had mucoid Pseudomonas, 10 had only' non-mucoid Pseudomonas. 5 had non-mucoid Pseudomonas intermittently, and 2 never had Pseudomonas cultured. However, of these latter two, one was newly diagnosed (patient 44, age 8 years).
As determined by x-ray score, physical exam, and pulmonary funct~on data, 35 of the 49 patients were in good clinical condition, 13 patients were i n moderate condition and one patient was i n poor condit~on. The patients were preselected on the basis of being able t o come off antibiotics for 48 hours before the blood was drawn. Thus, few patients i n poor condition were used. All of the patients whose serum consistently did not show inhibition were rn good condition (category A as defined above).
'While there is no correlation between age and degree of inhibition, individuals who fatled to show rnhibition were generally younser.
Sex also did not correlate with inhibition. Serum samples from 8 obligate heterozygotes alm did not demonstrate the inhibitory activlty.
Effect of Racterlal Characteristrcs
To determine whether thrs inhibitory phenomenon was specific for the source of Pseudomonas, 4 C F lsolates and 2 non-CF isolates were investigated (Table 3 ). Serum samples from six patients demonstrated similar results using different organisms regardless of the source of the organism. The only exception was patient 33, whose serum produced less inhibition of phagocytosis of a non-CF Pseudomonas than with his own orqanism. Serum samples from 3 other patlents showed relatively equal inhibition wlth this non-CF organism as compared with organisms from C F patients.
Characteristics of Inhibiting Activlty
Serum lnh~bltion of phagocytosis can arise from erther the presence of an inhibitory factor or from a serum deficiency. To drstbnguirh these possibilities, 4 paired serum samples from C F patlents and controls were m~x e d i n equal parts. The results shown i n Table 4 demonstrate that normal sera could not overcome the inhibitory effect. Thls Indicates the presence of an inhibitory factor rather than the lack of a necessary component. The Inhibitory activity could, however, be eradicated by serial dllution of CF serum into normal serum. A serum from the hrgh inhibitory group demonstrating 9 4 8 inhibition must be diluted w~t h normal serum more than 40 fold for complete loss of actrvity while a serum demonstrating 3796 i n h i b~t i w shows loss of activity at a 4 fold dilution i n the same normal serum.
The inhib~tory activity IS not lost upon exposure of serum to glass or upon freezlng the serum once. Table 5 shows the results with 7 serum samples before and after heating at 5 6 '~ for 30 minutes; none had a significant change i n the per cent inhibition of phagocytosis after heating.
DIXUSSWN
The alveolar macrophage is an important component i n the clearance of bacterra from the lung (9); efficient functioning of this cell is essent~al i n control of ~nfection. We have shown that ohagocytosls of Pseudomonas by both rabbit and human alveolar macrophaqes is s~gnificantlv ~nhlbited by C F serum. Thls serum effect is apparently speclfic for Pseudomonas since phagocytosis experiments with 5. aureus and S. marcescens demonstrated no s~gn~ficant inh~hitlon. The impairment a p p e a r s o be t6e result of the presrnce of a factor(s) rather than a lack of an opsonin as Biggar, et al. (1) postulated because the inhibitory effect could not be overcome i n mixing experiments wtth C F and control sera. IJnlike some other "CF factors" (4) . the inhibrtory factor is stable to freez~ng, heating and IS unaffected by exposure to glass.
Of the C F patlents studled to date, h patients have intermediate inhibitory actlvlty of 20-608 i n t h e~r serum and 4 patients do not exhibit the inh~brtory effect. I t may be that patlents with 20-60s inhibition have lower levels of the factor. The experiments us~ng diluted serum samples support this hypothesis. Of the 4 patients who do not exhibit the inhibitory factor, 2 are infants from whom Pseudomonas has never been cultured and the other two do not have mucoid Pseuc ,.?onas. Every patient who had mucold Pseudomonas has demonstrated inhibition, although a few inhibitory serum samples were from patrents who had non-mucoid Pseudomonas. Chronrc Pseudomonas Infection does not appear to be a necessary prerequisite, but the presence of the inhibitory actrvrty correlates well with a positive Pseudomonas culture history.
To evaluate the role of infection, the patients without the activity are being followed longitudinally to determine i f they acquire the activity after chronic infection with mucoid Pseudomonas. Obligate heterozygotes do not have the activity i n their serum. To further characterize the source of the factor, we are investigating non-CF patients with chronic Pseudomonas infections and non-CF patients with chronrc lung disease without Pseudomonas.
Since all C F serum samples do not exhibit inhibition, thls phenomenon may not be a direct result of a prlmary or intrinsrc C F defect hut rather may be an acquired characteristic. The phenomenon could result from a Pseudomonas induced alteration of the host defense system, such as non-opsonidng antibodies or other less well deflned serum components wh~ch alter either opsonization or the regulation of macrophage function (e.g., lymphokines). C F serum does not have a direct toxic effect on the rnacrophages slnce the cells remain functronal as evidenced by their ability to ohagocytize 5. aureus and 5. marcescens. Complement is probably not involved since heat does no? a m t h e 1i;hlbition.e presence of the inhibitory activity also does not appear to correlate with antibody titer as determined by bacterial agglutination. The serum titers of the CF patients seem low but they were determined only against the Pseudomonas used i n the phagocytosis assay. A patient may have a higher titer t o his own organism.
An alternate hypothes~s is that a bacterial property of the Pseudomonas could directly affect the macrophage or simply protect the bacteria from phagocytosis. However, if the inhibitory effect is the result of a bacterial product, i t does not appear to be strain specific since both C F and non-CF Reudomonas isolates give the same results i n the phagocytosrs assay. Non-mucoid isolates were used in the experiments presented in this paper because of the inability t o maintain the mucoid property. We have since isolated a stable strain which will be used i n subsequent studies.
Further studies are i n progress which will hopefully provide answers to some of these questions concerning the origrn and the i d e n t~t y of the activity. Slnce complete eradication of Pseudomonas i n the C F patient is virtually impossible with current modes of therapy, an understanding of this inhibitory phenomenon may provide insight into ways for improving host defense mechanisms i n the C F patient and thereby achieving effective control of infection.
I~i f f e r e n t culture vessels were used because of limited availability of chamber slides from the supplier.
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